Next Article in Journal
Design, Synthesis, and Antitumor Evaluation of Novel Pyrazolo[3,4-d]pyrimidine Derivatives
Previous Article in Journal
Development of Antimetastatic Drugs by Targeting Tumor Sialic Acids
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessArticle
Sci. Pharm. 2012, 80(3), 509-530; (registering DOI)

Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer Agents

Department of Pharmaceutical, Organic and Bioorganic Chemistry, Danylo Halytsky Lviv National Medical University, Pekarska 69, 79010, Lviv, Ukraine
Mutabilis, 102 Avenue Gaston Roussel, 93230 Romainville, France
Author to whom correspondence should be addressed.
Received: 2 April 2012 / Accepted: 3 May 2012 / Published: 3 May 2012
PDF [262 KB, uploaded 30 September 2016]


rel-(5aR,11bR)-3,5a,6,11b-tetrahydro-2Н,5Н-chromeno[4',3':4,5]thiopyrano[2,3-d][1,3]thiazol-2-ones formed by the stereoselective Knoevenagel-hetero-Diels-Alder reaction were functionalized at the nitrogen in position 3 via reactions of alkylation, cyanoethylation, and acylation. The synthesized compounds were evaluated for their anticancer activity in NCI60 cell lines. Among the tested compounds, 3f was found to be the most active candidate with the greatest influence on leukemia, non-small cell lung cancer, colon cancer, CNS cancer, melanoma, prostate cancer, and breast cancer subpanel cell lines with GI50 values over a range of 0.37–0.67 μM.
Keywords: Thiopyrano[2,3-d][1,3]thiazoles; Alkylation; Cyanoethylation; Anticancer activity; COMPARE analysis Thiopyrano[2,3-d][1,3]thiazoles; Alkylation; Cyanoethylation; Anticancer activity; COMPARE analysis
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

KRYSHCHYSHYN, A.; ATAMANYUK, D.; LESYK, R. Fused Thiopyrano[2,3-d]thiazole Derivatives as Potential Anticancer Agents. Sci. Pharm. 2012, 80, 509-530.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top